SMS Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹1,362cr+18.2% on Mar 2025
Shareholders' equity: ₹786cr+22.9% on Mar 2025
Total debt: ₹365cr+17.5% on Mar 2025
Cash and investments: ₹45.9cr+10.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	531	531	434	409
	122	34.7	30.3	33.2
	2.8	2.1	2.7	1.5
	0.0	0.0	0.4	1.1
	26.3	11.7	10.9	10.5
	11.2	9.9	7.9	7.6
	37.5	21.6	18.8	18.1
	31.3	9.0	13.9	5.6
	724	598	500	469
	351	285	234	223
	216	203	236	148
	45.9	41.4	36.0	7.4
	0.2	0.2	0.2	0.1
	3.4	9.9	3.3	6.6
	265	255	276	162
	21.4	14.6	22.8	19.0
	638	554	534	411
	1,362	1,153	1,034	880
Equity
	9.4	8.9	8.5	8.5
	776	631	528	452
	786	640	536	461
	0.0	0.0	—	0.0
	786	640	536	461
Liabilities
	172	139	122	121
	—	0.0	0.0	0.6
	172	139	122	122
	1.2	1.2	1.2	1.4
	50.8	48.1	42.8	41.0
	224	189	166	164
	193	171	158	131
	120	114	151	113
	31.8	33.4	16.4	0.9
	346	319	326	245
	0.9	1.1	1.0	1.0
	0.6	0.0	0.0	2.9
	5.8	4.6	4.8	5.5
	353	324	332	255
	577	513	498	419
	1,362	1,153	1,034	880
Assets — additional as-filed lines
	0.0	0.4	1.7	5.8
Trade payables — MSME split
	0.2	0.1	—	—
	120	114	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SMSPHARMA₹475.45

SMS Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersINDSWFTLAB SOLARA DCAL UNICHEMLAB GUFICBIO RPGLIFE HIKAL GUJTHEMMcap ₹4,453 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	409.5	434.2	530.8	531.2	531.2
+ Capital Work-in-Progress	33.2	30.3	34.7	121.6	121.6
+ Other Intangibles	1.5	2.7	2.1	2.8	2.8
+ Intangibles under Development	1.1	0.4	0.0	0.0	0.0
+ Non-current Investments	10.5	10.9	11.7	26.3	26.3
+ Other Non-current Financial Assets	7.6	7.9	9.9	11.2	11.2
Non-current Financial Assets	18.1	18.8	21.6	37.5	37.5
+ Other Non-current Assets	5.6	13.9	9.0	31.3	31.3
Total Non-current Assets	469.0	500.2	598.2	724.4	724.4
Current Assets
+ Inventories	223.5	233.7	284.7	351.2	351.2
+ Trade Receivables	148.3	236.2	203.2	215.9	215.9
+ Cash & Cash Equivalents	7.4	36.0	41.4	45.9	45.9
+ Other Bank Balances	0.1	0.2	0.2	0.2	0.2
+ Other Current Financial Assets	6.6	3.3	9.9	3.4	3.4
Current Financial Assets	162.4	275.7	254.7	265.4	265.4
+ Other Current Assets	19.0	22.8	14.6	21.4	21.4
Total Current Assets	410.6	533.9	554.5	638.0	638.0
Total Assets	879.6	1,034.1	1,152.7	1,362.4	1,362.4
Equity
+ Equity Share Capital	8.5	8.5	8.9	9.4	9.4
+ Other Equity / Reserves	452.1	527.9	630.8	776.4	776.4
Equity — Owners of Parent	460.5	536.3	639.6	785.8	785.8
+ Minority Interest	0.0	—	0.0	0.0	0.0
Total Equity	460.5	536.3	639.6	785.8	785.8
Liabilities
+ Borrowings — Non-current	121.1	122.1	139.4	171.6	171.6
+ Other Non-current Financial Liab	0.6	0.0	0.0	—	—
Non-current Financial Liabilities	121.7	122.1	139.4	171.6	171.6
+ Provisions — Non-current	1.4	1.2	1.2	1.2	1.2
+ Deferred Tax Liabilities	41.0	42.8	48.1	50.8	50.8
Non-current Liabilities	164.2	166.0	188.7	223.7	223.7
+ Borrowings — Current	131.4	158.1	171.4	193.4	193.4
+ Trade Payables	113.1	151.3	113.9	120.4	120.4
+ Other Current Financial Liab	0.9	16.4	33.4	31.8	31.8
Current Financial Liabilities	245.5	325.9	318.7	345.6	345.6
+ Provisions — Current	1.0	1.0	1.1	0.9	0.9
+ Current Tax Liabilities	2.9	0.0	0.0	0.6	0.6
+ Other Current Liabilities	5.5	4.8	4.6	5.8	5.8
Current Liabilities	254.9	331.7	324.4	353.0	353.0
Total Liabilities	419.1	497.8	513.0	576.6	576.6
Total Equity & Liabilities	879.6	1,034.1	1,152.7	1,362.4	1,362.4
Assets — additional as-filed lines
+ Current Tax Assets	5.8	1.7	0.4	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	0.1	0.2	0.2
+ Dues to Other Creditors — Current	—	—	113.8	120.2	120.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.